Atrial fibrillation Circulatory System Atrial fibrillation
Conditions
Interventions
With an assumed success rate of the monophasic shock wave form between 79% and 90%, we calculated a group size of 100 patients per group to achieve a statistical power of 0.8 (beta error 0.2) and a tw
Sponsors
University Hospital Münster (Germany)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: All patients presenting with persistent atrial fibrillation and an indication for external cardioversion in the Department of Cardiology of the University Hospital Münster, Germany were consecutively screened for the trial. Inclusion criteria: 1. A clinical indication for external cardioversion of atrial fibrillation 2. Documented atrial fibrillation prior to the procedure 3. To minimise thrombo-embolic complications, documented oral anticoagulation with phenprocoumon (international normalised ratio [INR] 2 - 3) for three weeks or exclusion of left atrial thrombi by trans-oesophageal echocardiography directly prior to the cardioversion procedure was required. Continuation of anticoagulation after cardioversion was recommended for all trial patients.
Exclusion criteria
Exclusion criteria: Patients presenting with atrial flutter or atrial tachycardias
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Successful restoration of sinus rhythm by the cardioversion shock. | — |
Secondary
| Measure | Time frame |
|---|---|
| Not provided at time of registration | — |
Countries
Germany
Outcome results
None listed